Document is current
Any future updates will be listed below
-
Authors
Hoffmann, Laura
Hatz, Katja https://orcid.org/0000-0003-2807-0310
- License Information
-
More Information
Article History
Received: 8 January 2026
Accepted: 13 February 2026
First Online: 14 March 2026
Declarations
:
: Laura Hoffmann received travel grants from Bayer and Roche. Katja Hatz received fees for consultancies and advisory board participation from Novartis, Bayer, Roche, Allergan/AbbVie.
: Approval to conduct this study was obtained from the local ethics committee Ethikkommission Nordwestschweiz (EKNZ; BASEC No 2025–01725). The study was conducted according to the Tenets of the Declaration of Helsinki. Since the study represents a safety analysis, all intravitreal injections were included. Individual patient consent was given through our general consent form for subjects explicitly mentioned in the figures.
